ID   MG63/DXR1000
AC   CVCL_9U34
DR   Wikidata; Q54905420
RX   PubMed=10854558;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Homozygous for CDKN2A deletion (from parent cell line).
CC   Derived from metastatic site: Bone; left femur.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-10-20; Version: 6
//
RX   PubMed=10854558; DOI=10.3892/or.7.4.859;
RA   Oda Y., Matsumoto Y., Harimaya K., Iwamoto Y., Tsuneyoshi M.;
RT   "Establishment of new multidrug-resistant human osteosarcoma cell
RT   lines.";
RL   Oncol. Rep. 7:859-866(2000).
//